Interleukin-22 genetic polymorphisms and risk of colon cancer

Cancer Causes and Control

Volumn 21, Issue 8, 2010, Pages 1165-1170

  Thompson, Cheryl L ^a,b   Plummer, Sarah J ^c   Tucker, Thomas C ^d   Casey, Graham ^b,c   Li, Li ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Case Center for Transdisciplinary Research on Energetics and Cancer   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Association; Case control study; Colon cancer; IL 22; SNP

Indexed keywords

ADENINE; CYTOSINE; GUANINE; INTERLEUKIN 22; NONSTEROID ANTIINFLAMMATORY AGENT; THYMINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; AGE; ALLELE; ARTICLE; BODY MASS; CANCER RISK; COLON CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; COLON TUMOR; GENETICS; IMMUNOLOGY; MIDDLE AGED;

CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKINS; LIFE STYLE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77955718188     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9542-5     Document Type: Article

References (18)

1. AG Dalgleish K O'Byrne 2006 Inflammation and cancer: the role of the immune response and angiogenesis Cancer Treat Res 130 1 38 10.1007/0-387-26283- 0-1 1:CAS:528:DC%2BD1MXhtVajtL8%3D 16610701
2. WW Lin M Karin 2007 A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 117 1175 1183 10.1172/JCI31537 1:CAS:528:DC%2BD2sXlt1Omtrk%3D 17476347
3. E Vivier H Spits T Cupedo 2008 Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol 9 229 234 10.1038/nri2522
4. PW Wu J Li SR Kodangattil, et al. 2008 IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22 J Mol Biol 382 1168 1183 10.1016/j.jmb.2008.07.046 1:CAS:528: DC%2BD1cXhtFWlt7nO 18675824
5. D Lejeune L Dumoutier S Constantinescu W Kruijer JJ Schuringa JC Renauld 2002 Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10 J Biol Chem 277 33676 33682 10.1074/jbc.M204204200 1:CAS:528:DC%2BD38Xnt1Srsr8%3D 12087100
6. E Ziesche M Bachmann H Kleinert J Pfeilschifter H Muhl 2007 The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells J Biol Chem 282 16006 16015 10.1074/jbc.M611040200 1:CAS:528:DC%2BD2sXlvVajs7k%3D 17438334
7. A Andoh Z Zhang O Inatomi, et al. 2005 Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts Gastroenterology 129 969 984 10.1053/j.gastro.2005.06.071 1:CAS:528:DC%2BD2MXhtV2isrnO 16143135
8. GF Weber FC Gaertner W Erl, et al. 2006 IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase J Immunol 177 8266 8272 1:CAS:528:DC%2BD28Xht1WrsLbI 17114505
9. L Li SJ Plummer CL Thompson TC Tucker G Casey 2008 Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk Clin Cancer Res 14 633 637 10.1158/1078-0432.CCR-07-1211 1:CAS:528:DC%2BD1cXhsFyksb0%3D 18245521
10. PI de Bakker R Yelensky I Pe'er SB Gabriel MJ Daly D Altshuler 2005 Efficiency and power in genetic association studies Nat Genet 37 1217 1223 10.1038/ng1669 16244653
11. SJ Aujla YR Chan M Zheng, et al. 2008 IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia Nat Med 14 275 281 10.1038/nm1710 1:CAS:528:DC%2BD1cXivFOrtLg%3D 18264110
12. Y Zheng PA Valdez DM Danilenko, et al. 2008 Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens Nat Med 14 282 289 10.1038/nm1720 1:CAS:528:DC%2BD1cXivFOrtLw%3D 18264109
13. T Cacev S Radosevic S Krizanac S Kapitanovic 2008 Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression Carcinogenesis 29 1572 1580 10.1093/carcin/bgn164 1:CAS:528:DC%2BD1cXhtVSis7zN 18628251
14. C Poole 1999 Controls who experienced hypothetical causal intermediates should not be excluded from case-control studies Am J Epidemiol 150 547 551 1:STN:280:DyaK1MvhvVGhtg%3D%3D 10489992
15. CL Thompson SJ Plummer LS Acheson TC Tucker G Casey L Li 2009 Association of common genetic variants in SMAD7 and risk of colon cancer Carcinogenesis 30 982 986 10.1093/carcin/bgp086 1:CAS:528:DC%2BD1MXntVWjsbs%3D 19357349
16. L Li SJ Plummer CL Thompson, et al. 2008 A common 8q24 variant and the risk of colon cancer: a population-based case-control study Cancer Epidemiol Biomarkers Prev 17 339 342 10.1158/1055-9965.EPI-07-0713 18268117
17. KJ Rothman 1990 No adjustments are needed for multiple comparisons Epidemiology 1 43 46 10.1097/00001648-199001000-00010 1:STN:280: DyaK3M7otlShtA%3D%3D 2081237
18. KN Conneely M Boehnke 2007 So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests Am J Hum Genet 81 1158 1168 10.1086/522036 1:CAS:528:DC%2BD2sXhtl2ju77N